Skip to main content
Clinical Trials/NCT03528811
NCT03528811
Unknown
Phase 1

Evaluation of Microcirculation of Peripheral Vascular Disease in Diabetes

Shanghai 10th People's Hospital1 site in 1 country300 target enrollmentAugust 1, 2016

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Peripheral Vascular Disease in Diabetes
Sponsor
Shanghai 10th People's Hospital
Enrollment
300
Locations
1
Primary Endpoint
Coincidence rate of "5 points test of Tongji university"
Last Updated
7 years ago

Overview

Brief Summary

The main aim of the present study was to evaluate the microcirculation of peripheral vascular disease in diabetes.

Registry
clinicaltrials.gov
Start Date
August 1, 2016
End Date
July 31, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Shanghai 10th People's Hospital
Responsible Party
Principal Investigator
Principal Investigator

Maoquan Li

Chief Physician

Shanghai 10th People's Hospital

Eligibility Criteria

Inclusion Criteria

  • 1.Patients with Peripheral vascular disease with or without diabetes. 2.Rutherford class 2-
  • 3.Target lesions with a diameter reduction of at least 50% on angiography, and without past history of any intervention.
  • 4.Target vessel with 2.0--10.0mm in diameter and having a lesion of about 4cm-20cm in length.
  • 5.Written informed consent signed by the patients or representatives

Exclusion Criteria

  • 1.Previous bypass surgery or stent placement at the ipsilateral lower limb 2.History of intolerance to antiplatelet therapy, heparin, or contrast media. 3.Bleeding diathesis; 4.Active systemic bacterial infection; 5.Severely impaired renal function (serum creatinine level \> 2.5 mg/dL. Expected survival time of less than 24 months

Outcomes

Primary Outcomes

Coincidence rate of "5 points test of Tongji university"

Time Frame: 12 months

The primary study endpoint was that the coincidence rate of evaluating the microcirculation by the newly-established "5 points test of Tongji university" attains over 95% before and after operations as assessed by digital substraction angiography (DSA).

Study Sites (1)

Loading locations...

Similar Trials